Year: 2019
Type: review
Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that has no effective treatment. The lack of any specific biomarker that can help in the diagnosis or prognosis of ALS has made the identification of biomarkers an urgent challenge. Multiple panels have shown alterations in levels of numerous cytokines in ALS, supporting the contribution of neuroinflammation to the progressive motor neuron loss. However, none of them is fully sensitive and specific enough to become a universal biomarker for ALS. This review gathers the numerous circulating cytokines that have been found dysregulated in both ALS animal models and patients. Particularly, it highlights the opposing results found in the literature to date, and points out another potential application of inflammatory cytokines as therapeutic targets.
DOI: 10.3390/ijms20112759
Authors: Laura Moreno-Martinez(Conceptualization, Investigation, Resources, Writing – original draft), Ana Cristina Calvo(Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing – review & editing), María Jesús Muñoz(Conceptualization, Supervision, Visualization), Rosario Osta(Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,824
OpenAlex ID: W2948784713
